D. E. Shaw & Co., Inc. Vanda Pharmaceuticals Inc. Call Options Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VNDA
# of Institutions
147Shares Held
49.6MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$46 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$24.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$19.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$13.4 Million0.03% of portfolio
-
Tang Capital Management LLC San Diego, CA1.75MShares$9.9 Million0.88% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $320M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...